April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Scleritis in Australia: Disease Associations and Ocular Complications
Author Affiliations & Notes
  • Julie L Morrison
    Centre for Eye Research Australia, University of Melbourne, East Melbourne, VIC, Australia
  • Ethan Nguyen
    Sydney Eye Hospital, Sydney, NSW, Australia
    Save Sight Institute, Sydney Medical School University of Sydney, Sydney, NSW, Australia
  • Jessica Brennan
    Centre for Eye Research Australia, University of Melbourne, East Melbourne, VIC, Australia
  • Richard Stawell
    Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia
  • Lyndell L Lim
    Centre for Eye Research Australia, University of Melbourne, East Melbourne, VIC, Australia
    Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia
  • Peter J McCluskey
    Save Sight Institute, Sydney Medical School University of Sydney, Sydney, NSW, Australia
  • Footnotes
    Commercial Relationships Julie Morrison, None; Ethan Nguyen, None; Jessica Brennan, None; Richard Stawell, None; Lyndell Lim, None; Peter McCluskey, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2513. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Julie L Morrison, Ethan Nguyen, Jessica Brennan, Richard Stawell, Lyndell L Lim, Peter J McCluskey; Scleritis in Australia: Disease Associations and Ocular Complications. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2513.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Scleritis is a rare ocular inflammatory condition which has the potential for significant visual loss. This retrospective review looks at the demographics, clinical features and complications associated with infectious and non-infectious scleritis in an Australian population.

 
Methods
 

Retrospective chart review of 90 patients with scleritis from three Australian tertiary referral centers from 1988 to 2013. Data collected included type of scleritis, demographics, ocular complications, associated systemic disease and treatments.

 
Results
 

The mean age of onset was 50 years of age (range 8 to 85). Females accounted for 62% of presentations and had an earlier mean age of onset (46 vs. 57, p=0.01).Nine of the 90 subjects had infectious scleritis (tuberculosis n=3, herpes zoster ophthalmicus n=2, other n=4). Of the non-infectious scleritis, the commonest form was diffuse (45%), followed by nodular (23%), necrotising (16%) and posterior (16%). The majority of cases (75%) were unilateral, with diffuse scleritis being more likely to be bilateral than other types (39%,p=0.008). Forty percent were found to have an associated systemic disease, with diffuse anterior scleritis the most likely to be associated with systemic disease than any other type of scleritis (45%). The most commonly associated systemic disease was rheumatoid arthritis (RA, n=9, 29%), followed by Wegener’s granulomatosis (n=5, 16%). Those with RA were more likely to have bilateral involvement (56%, p=0.037). Necrotising disease was more likely than non-necrotising disease to have associated corneal involvement (p=0.019), cataract (p=0019) and keratitis (p=0.032). Those with posterior involvement were more likely to have reduced visual acuity (p=0.010), due to its higher association with uveal effusion (p=0.012), macular edema (p=0.028) and retinal detachment (p<0.001).

 
Conclusions
 

This is the first study to categorize an Australian population of scleritis patients. Consistent with previous studies, we found females were more likely to suffer from scleritis and present at a younger age. Necrotizing scleritis or scleritis with posterior involvement were more likely to be associated with ocular complications. A higher proportion of posterior scleritis was identified compared to previous studies.

 
Keywords: 708 sclera • 557 inflammation • 462 clinical (human) or epidemiologic studies: outcomes/complications  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×